Abrocitinib Boosts Skin Clearance and Itch Relief in AD
9h agoen
From the article
Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to dupilumab, a post hoc study shows. Medscape News UK
Continue reading on MedscapeYou might also wanna read
The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching
clinicaltrials.gov·8d ago
Soluble bacterial lipopeptides suppress gasdermin D-associated IL-33 release in keratinocytes and atopic dermatitis in mice
doi.org·22d ago
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
clinicaltrials.gov·1d ago
A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
clinicaltrials.gov·17h ago
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
clinicaltrials.gov·1d ago
Clinical trial finds existing drug dupilumab may treat rare GI disease eosinophilic gastritis
A clinical trial supported by the Rare Diseases Clinical Research Network (RDCRN) found that dupilumab, an existing drug, may be an effectiv
ncats.nih.gov·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.